⌘K

Login Start Free

Home/Filings/4/0001213900-21-030618

4//SEC Filing

Runge Jeffrey W. 4

Accession 0001213900-21-030618

CIK 0001726711other

View on SEC.gov Company Profile

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 5:38 PM ET

Size

11.9 KB

Accession

0001213900-21-030618

Insider Transaction Report

Form 4

Period: 2021-06-01

Aditx Therapeutics, Inc.ADTX

Runge Jeffrey W.

Director

Transactions

Purchase
Common Stock
2021-06-01$2.94/sh+700$2,055→ 3,200 total
Purchase
Common Stock
2021-06-01$2.94/sh+3,000$8,820→ 12,500 total
Purchase
Common Stock
2021-06-01$2.94/sh+700$2,061→ 3,900 total
Purchase
Common Stock
2021-06-01$2.93/sh+1,600$4,688→ 5,500 total
Purchase
Common Stock
2021-06-01$2.93/sh+2,000$5,860→ 9,500 total
Purchase
Common Stock
2021-06-01$2.93/sh+2,000$5,860→ 7,500 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

Aditx Therapeutics, Inc.

CIK 0001726711

Entity typeother

Related Parties

1

filerCIK 0001479091

Filing Metadata

Form type: 4
Filed: Jun 1, 8:00 PM ET
Accepted: Jun 2, 5:38 PM ET
Size: 11.9 KB

View on SEC.gov